Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 3/20 | 0.31 |
| ▸ | CES1 | P23141 | 3/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.31 |
| ▸ | FABP3 | P05413 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Zinc Ion SCHEMBL19253790 | 0.84 | FABP3 (0.44) | FABP3 | |
| Zinc Ion SCHEMBL19253796 | 0.81 | CA1 (0.42) | FABP3 | |
| Zinc Ion SCHEMBL18204925 | 0.80 | CES2 (0.56) | CES2CES1TSHRFABP3 | |
| Zinc Ion SCHEMBL8745953 | 0.80 | CES2 (0.56) | CES2CES1TSHRFABP3 | |
| SCHEMBL19253792 | 0.79 | FABP3 (0.44) | FABP3 | |
| SCHEMBL19253794 | 0.79 | FABP3 (0.44) | FABP3 | |
| SCHEMBL10870322 | 0.79 | CA1 (0.46) | NFKB1FABP3 | |
| SCHEMBL9755639 | 0.79 | CA1 (0.46) | NFKB1FABP3 | |
| Zinc Ion SCHEMBL18204922 | 0.77 | CES2 (0.54) | CES2CES1TSHRFABP3 | |
| Potassium Ion SCHEMBL17536043 | 0.76 | LMNA (0.55) | LMNATSHRNFKB1PMP22FABP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9924715-B2 | Zinc or copper (II) salt and use thereof as a biocide | LABORATORIYA BIO ZET, LLC (RU) | 2018-03-27 | — | — | US | disclosed |
| US-20170238545-A1 | Zinc or Copper (II) Salt and Use Thereof as a Biocide | LABORATORIYA BIO ZET, LLC (RU) | 2017-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170238545-A1 | Zinc or Copper (II) Salt and Use Thereof as a Biocide | SOD1, AOC2, SOD3 | CES2 38/4885CES1 357/4885LMNA 4386/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.